Discipline Decisions (October 2025)

• Failed to take appropriate steps to verify the identity of the owner and/or operator of the Pharmacy before agreeing to act as Designated Manager;
• Failed to take appropriate steps to verify that the Pharmacy was not being used for an improper purpose;
• Failed to exercise appropriate oversight over the Pharmacy;
• Failed to take appropriate steps upon the closure of the Pharmacy;
• Failed to take appropriate steps to prevent the loss, theft, diversion, and/or misappropriation of narcotics and/or controlled substances from the Pharmacy; and/or 
• Failed to ensure that the standards for accreditation of the Pharmacy were maintained. 

In particular, the Panel found that the Registrant: 

• Failed to maintain a standard of practice of the profession;
• Contravened the Drug and Pharmacies Regulation Act (“DPRA”), as amended, and/or the regulations under the DPRA, and in particular: 
  • section 141 of the DPRA; 
  • sections 18-21 of O. Reg 264/16; 
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional. 

The Panel imposed an Order, as follows: 

1. A reprimand;

2. Directing the Registrar to suspend the Registrant’s certificate of registration for a period of 13 months with 1 month of the suspension to be remitted on the condition that the Registrant completes the remedial requirements specified in paragraphs 3(a), (b), and (c). The suspension shall commence on July 15, 2025 and run without interruption until July 14, 2026, inclusive. If the remitted portion of the suspension is required to be served by the Registrant because she fails to complete the remedial requirements specified in paragraphs 3(a), (b), and (c), that portion of the suspension will commence on February 15, 2027 and continue until March 14, 2027, inclusive.  
3. Directing the Registrar to impose specified terms, conditions or limitations on the Registrant’s certificate of registration, including:
   1. The Registrant shall successfully complete, at her own expense and within 12 months of the date of this Order, the ProBE Program on Professional / Problem Based Ethics for Healthcare Professionals, with an unconditional pass; 
   2. The Registrant shall successfully complete, within 12 months of the date of this Order, all of the College’s jurisprudence e-Learning modules and the Jurisprudence, Ethics and Professionalism exam;  
   3. The Registrant shall successfully complete, at her own expense, and within 18 months of the date of this Order, a mentorship program focusing on the issues raised by the facts and findings of professional misconduct in this case. The mentorship program shall include the following terms: 
      1. Within 12 months of the date of this Order, the College shall assign the Registrant a practice mentor and the Registrant shall retain the practice mentor at her own expense;  
      2. The mentor and the Registrant shall meet for the purpose of reviewing the Registrant’s practice with respect to the concerns raised by the facts and findings of professional misconduct in this case. The total number of sessions between the mentor and the Registrant will be at the sole discretion of the mentor, but shall be no less than 3;  
      3. The Registrant shall provide the mentor with the following documents related to this proceeding: 
         1. a copy of the Agreed Statement of Facts;  
         2. a copy of this Joint Submission on Order; and  
         3. a copy of the Decision and Reasons of the Discipline Panel, when available.  
      4. The Registrant shall develop a learning plan with the mentor to comprehensively address the remediation required; 
      5. The Registrant shall demonstrate to the mentor that she has successfully achieved all of the goals of the learning plan; and 
      6. The Registrant shall require the mentor to report the results of the mentorship program to the College within 19 months of the date of this Order. Such report shall include, but is not limited to:  
         1. the learning plan; and  
         2. the Mentor’s Reporting Form as provided by the College, which shall include the mentor’s assessment of the Registrant’s success in meeting the goals of the learning plan. 
   4. The Registrant shall be prohibited from acting as the Designated Manager of any pharmacy. After a period of five years from the date of this Order, the Registrant may apply to the Discipline Committee to seek to have this term, condition, or limitation removed. 
4. Costs to the College in the amount of $10,000. 

In its reprimand, the Panel noted that, as a member of the profession of pharmacy, it is important that the Registrant understand that ethics, trust, and professional conduct are at the core of the practice of pharmacy. 

The Panel indicated that it was appalled by the Registrant’s lack of understanding of the standards of practice of the profession. The role of Designated Manager is one of serious responsibilities that include the obligation to ensure that the entire operation of the pharmacy is overseen in accordance with the College’s Standards of Practice. Her lack of responsibility and accountability in ensuring that the pharmacy operations adhered to relevant legislation, guidelines, and procedures is alarming. Her conduct resulted in the misappropriation of narcotics and controlled substances to the general public, which puts the public at incredible risk.   

The Panel expressed its expectation that the remediation ordered will put the Registrant in a better position to understand her professional obligations as a pharmacist, that she has learned from this experience, and that she will not appear before a panel of the Discipline Committee again. 

• Failed to maintain a standard of practice of the profession;
• Failed to carry out or abide by an undertaking given to the College or breached an agreement with the College, a Committee of the College or the Registrar;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional.

At the same hearing, the Panel made findings of proprietary misconduct against Noor Nooruzzaman, as Designated Manager of Noor Healthcare Pharmacy in Mississauga, Ontario (the “Pharmacy”), and as the Director of Nooruzzaman Inc., c.o.b. Noor Healthcare Pharmacy, and Nooruzzaman Inc., as the holder of Certificate of Accreditation #303588 for the Pharmacy, in that they:

1. Permitted, consented to or approved, either expressly or by implication, the operation of the Pharmacy without a pharmacist physically present on or about September 30, 2021; and/or
2. Failed to adequately maintain the pharmacy in a safe, clean, and/or orderly fashion with respect to:
   1. the inadequate storage of medication awaiting destruction and sharps containers in or about September 2021; and/or
   2. the inadequate monitoring/and or maintenance of fridge temperatures between in or about October 2019 and/or in or about September 2021; and/or
3. Failed to have adequate systems in place and/or adequate recordkeeping with respect to: 
   1. Conducting and/or maintaining a record of adequate inventory counts and/or reconciliations for narcotics, controlled drugs and/or targeted substances from in or about January 9, 2019 to in or about October 29, 2019; and/or in or about March, April, August and/or September 2021; and/or
   2. recording accurate information regarding prescriptions, specifically with respect to unsigned prescription hard copies on one or more occasions in and around April 2019, October 2019 and/or September 2021; and/or
   3. maintaining records in a manner that is auditable, traceable and/or allows for their easy retrieval with respect to Rx […] in and around October 2019 and Rxs […], […], and/or […] in and around September 2021

In particular, the Panel found that Noor Nooruzzaman, as Designated Manager of Noor Healthcare Pharmacy in Mississauga, Ontario (the “Pharmacy”), and as the Director of Nooruzzaman Inc., c.o.b. Noor Healthcare Pharmacy, and Nooruzzaman Inc., as the holder of Certificate of Accreditation #303588 for the Pharmacy:

• Failed to maintain any of the standards of accreditation;
• Failed to keep documents as required respecting patients, the operation of the pharmacy and/or the practice of members practicing in the pharmacy;
• Contravened the Drug and Pharmacies Regulation Act, the Pharmacy Act, 1991, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act, the Ontario Drug Benefits Act or the regulations under those Acts, in particular: section 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal, provincial or territorial law or any municipal bylaw with respect to the distribution, purchase, sale and/or dispensing of any drug product, where the purpose of the law or bylaw is to protect or promote public health or where the law or bylaw relates to the operation of the pharmacy or the provision of pharmacy services, in particular: 
  • Section 43 of the Narcotic Control Regulations, as amended; and/or 
  • section G.03.012 under the Food and Drug Regulations, as amended; and/or 
  • section 72 of the Benzodiazepines and Other Targeted Substances Regulations, as amended;

Engaged in conduct or performed an act relevant to the operation of a pharmacy that, having regard to the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;
2. Directing the Registrar to impose specified terms, conditions or limitations on the Registrant’s certificate of registration, including:
   1. The Registrant must successfully complete, at his own expense, and within 18 months of the date this Order become final, a mentorship program. The mentorship program must focus on the concerns raised in the audit reports from the assessments dated January 9, 2019, April 8, 2019, October 29, 2019, and September 30, 2021 (the “Audit Reports”) as well as the roles and responsibilities of a Designated Manager. The mentorship program shall include the following terms:
      1. The Registrant shall retain, at his own expense, a mentor selected and approved by the College;
      2. The mentor and the Registrant shall meet for the purpose of reviewing the Registrant’s practice with respect to the concerns raised in the Audit Reports. The total number of sessions between the mentor and the Registrant will be at the sole discretion of the mentor, but shall be no less than four (4);
      3. The Registrant shall provide the mentor with the following documents related to this proceeding:
         1. a copy of the Notices of Hearing;
         2. a copy of the Agreed Statement of Facts;
         3. a copy of this Joint Submission on Order;
         4. a copy of the Decision and Reasons of the Discipline Panel, when available;
         5. a copy of the Audit Reports as identified in the Agreed Statement of Facts; and
         6. copies of the ICRC decisions in files 2019172 (dated August 18, 2020) and 2021651 (dated January 17, 2023).
      4. The Registrant shall develop a learning plan with the mentor to comprehensively address the issues raised in the Audit Reports and the role and responsibilities of a Designated Manager. The learning plan shall include, but is not limited to, successful completion by the Registrant of the College’s Designated Manager e-Learning Module and its associated Certificate of Completion;
      5. The Registrant shall demonstrate to the mentor that he has successfully achieved all of the goals of the learning plan; and
      6. The Registrant shall require the mentor to report the results of the mentorship program to the College within eighteen (18) months of the date this Order become final. Such report shall include, but is not limited to:
         1. the Registrant’s Certificate of Completion of the College’s Designated Manager e-Learning Module;
         2. the learning plan; and
         3. the Mentor’s Reporting Form as provided by the College, which shall include the mentor’s assessment of the Registrant’s success in meeting the goals of the learning plan;
   2. The Registrant must successfully complete, at his own expense, an ethics course with Gail Siskind, or another professional ethics consultant chosen by the College, to be designed by the consultant, for the purpose of addressing the professional and ethical obligations arising in the Registrant’s case, within twelve (12) months of the date this Order become final. The following terms shall apply to the course:
      1. the number of sessions shall be at the discretion of the consultant, but shall be at least three (3) meetings;
      2. the manner of attendance at the session(s) (e.g. in person, via video conference, etc.) is a matter to be discussed in advance between the Registrant and the consultant, but shall ultimately be at the discretion of the consultant;
      3. the Registrant shall be responsible for the cost of the course;
      4. the Registrant shall provide to the consultant, in advance of the course, a copy of the Panel’s Reasons for Decision (if available), and the Agreed Statement of Facts and Joint Submission as to Order; and
      5. the Registrant shall request a report from the consultant confirming that the Registrant has completed the course to the satisfaction of the consultant and provide the report to the College within twelve (12) months of the date this Order become final.
   3. The Registrant shall be prohibited from acting as a Designated Manager in any pharmacy until the date on which the College is provided with a mentorship report, satisfactory to the College, demonstrating that the Registrant has successfully completed the mentorship program set out in paragraph 3(a);
   4. The Registrant shall successfully complete, at his own expense, the Jurisprudence exam offered by the College within twelve (12) months of the date this Order become final;
   5. The Registrant’s practice and the operation of any pharmacy in which he has a proprietary interest and/or is the Designated Manager shall be subject to Compliance Audit Reviews (“CAR” or “CARs”) by the College. The following terms apply to the CARs:
      1. The College will be entitled to conduct any CAR for a period of two (2) years from the date on which the mentorship program set out in paragraph 3(a) is satisfied (“CARs Period”);
      2. If the Registrant ceases to act as a Designated Manger and/or have a proprietary interest in any pharmacy at any time within the two (2) years specified in subparagraph 3e(i) above, such that the College is unable to conduct any CARs, then the CARs Period shall be paused and shall resume on the date on which the Registrant obtains a place of practice and/or a proprietary interest in a pharmacy, and in such circumstances:
         1. The Registrant shall notify the College immediately, in writing, if he is no longer acting as a Designated Manager and/or no longer holds a proprietary interest in a pharmacy at any point(s) during any times that the CARs Period remains active; and
         2. If the CARs Period is paused at any time(s), the Registrant shall notify the College, in writing, when he commences acting as a Designated Manager and/or obtains a proprietary interest in a pharmacy, at which point the CARs Period shall resume and shall continue until a total period of two (2) years has been achieved;
      3. The CARs will be conducted either in person or through a remote or virtual method by a representative of the College at the Registrant’s place of practice and/or at any pharmacy in which he holds a proprietary interest, at such times as the College may determine;
      4. During any CARs, the College representative will be entitled to review and examine the Registrant’s practice, or the practice and operation of any pharmacy in which the Registrant holds a proprietary interest and/or acts as a Designated Manager;
      5. The CARs are in addition to any routine inspections conducted by the College pursuant to the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4., s.148, and are not substitute for such inspections;
      6. The Registrant shall fully cooperate with the College representative during the CARs; and
      7. The Registrant shall pay to the College in respect of such CARs the amount of $1,000.00 per CAR, immediately after each CAR is completed, with the total amount to be paid by the Registrant not to exceed $3,000, regardless of the number of CARs and/or attendances conducted by the College.
3. Directing the Registrar to suspend the Registrant’s certificate of registration for a period of seven (7) months commencing on the date this Order becomes final.
4. Costs to the College in the amount of $35,000.

The reprimand in this matter remains outstanding.